Preclinical vascular injury models show measurable effects within 24 weeks of peptide administration, but chronic venous insufficiency develops over years and involves more complex pathology than acute experimental injuries
Zamorskii II, Shchudrova TS, Zeleniuk VG, Linkova NS, Nichik TE, Khavinson VK (2019)
Common peptides such as sermorelin are carefully selected based on individual health needs, lab results, and wellness goals
Tian, S., Huang, Q., Fang, Y
doi: 10.1160/TH12-07-0486 179
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)